United Asset Strategies’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-6,927
| Closed | -$909K | – | 229 |
|
2022
Q4 | $909K | Buy |
+6,927
| New | +$909K | 0.13% | 141 |
|
2022
Q3 | – | Sell |
-5,607
| Closed | -$660K | – | 218 |
|
2022
Q2 | $660K | Sell |
5,607
-286
| -5% | -$33.7K | 0.1% | 143 |
|
2022
Q1 | $768K | Buy |
5,893
+297
| +5% | +$38.7K | 0.1% | 133 |
|
2021
Q4 | $854K | Buy |
5,596
+3,792
| +210% | +$579K | 0.1% | 131 |
|
2021
Q3 | $292K | Sell |
1,804
-407
| -18% | -$65.9K | 0.04% | 175 |
|
2021
Q2 | $362K | Sell |
2,211
-857
| -28% | -$140K | 0.05% | 165 |
|
2021
Q1 | $462K | Sell |
3,068
-1,155
| -27% | -$174K | 0.07% | 152 |
|
2020
Q4 | $640K | Sell |
4,223
-545
| -11% | -$82.6K | 0.1% | 135 |
|
2020
Q3 | $646K | Sell |
4,768
-1,451
| -23% | -$197K | 0.12% | 112 |
|
2020
Q2 | $850K | Sell |
6,219
-789
| -11% | -$108K | 0.17% | 102 |
|
2020
Q1 | $755K | Sell |
7,008
-740
| -10% | -$79.7K | 0.19% | 98 |
|
2019
Q4 | $934K | Sell |
7,748
-124
| -2% | -$14.9K | 0.18% | 102 |
|
2019
Q3 | $783K | Sell |
7,872
-950
| -11% | -$94.5K | 0.17% | 109 |
|
2019
Q2 | $962K | Sell |
8,822
-731
| -8% | -$79.7K | 0.22% | 98 |
|
2019
Q1 | $1.07M | Sell |
9,553
-80
| -0.8% | -$8.94K | 0.25% | 98 |
|
2018
Q4 | $929K | Buy |
9,633
+3,362
| +54% | +$324K | 0.25% | 90 |
|
2018
Q3 | $765K | Sell |
6,271
-90
| -1% | -$11K | 0.18% | 110 |
|
2018
Q2 | $699K | Sell |
6,361
-195
| -3% | -$21.4K | 0.18% | 113 |
|
2018
Q1 | $700K | Buy |
6,556
+411
| +7% | +$43.9K | 0.21% | 107 |
|
2017
Q4 | $656K | Buy |
+6,145
| New | +$656K | 0.18% | 112 |
|